Zarak Hassan Khan
Zarak Hassan Khan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abdulazeez Swaiti
Department of Internal Medicine, ECU Health Medical Center, Greenville, NC
1 shared publication Aun Shah
Creighton University
1 shared publication- Danielle Hoo-Fatt
Department of Gastroenterology, ECU Health Medical Center, Greenville, NC
1 shared publication Hassam Ali
East Carolina University/Brody School of Medicine
1 shared publication- Hassam Ali
Department of Gastroenterology, Hepatology and Nutrition, East Carolina University/Brody School of Medicine, Greenville, NC
1 shared publication - Jinye Liu
Department of Internal Medicine, ECU Health Medical Center, Greenville, NC
1 shared publication
Latest Publications
- Open Access
- 1 August 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (8) , e01802
Candida glabrata Acalculous Cholecystitis in an Immunocompetent Host
Acalculous cholecystitis (AC) is an inflammatory condition of the gallbladder without the presence of gallstones. Although far less common than calculus cholecystitis, AC is associated with a mortality rate 10 times higher than that of calculus cholecystitis. While normally due to bacterial pathogens, opportunistic ones such as the fungi Candida species (spp) can be rare causative agents of AC, typically observed in those with underlying malignancy or immunosuppression. In this study, we present an unusual case of an immunocompetent patient who was afflicted by fluconazole-resistant Candida glabrata AC. Our case highlights the complexity of this diagnosis and the challenges providers may encounter while treating the underlying infection.
- 1 August 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (8) , e01802
Open AccessCandida glabrata Acalculous Cholecystitis in an Immunocompetent Host
Acalculous cholecystitis (AC) is an inflammatory condition of the gallbladder without the presence of gallstones. Although far less common than calculus cholecystitis, AC is associated with a mortality rate 10 times higher than that of calculus cholecystitis. While normally due to bacterial pathogens, opportunistic ones such as the fungi Candida species (spp) can be rare causative agents of AC, typically observed in those with underlying malignancy or immunosuppression. In this study, we present an unusual case of an immunocompetent patient who was afflicted by fluconazole-resistant Candida glabrata AC. Our case highlights the complexity of this diagnosis and the challenges providers may encounter while treating the underlying infection.
- Open Access
- 29 January 2024
- Published by Springer Nature in Research Square
Gender-Based Disparities in Clostridium Difficile Infections in the United States: A Population-Based Study
Introduction Clostridium difficile infection (CDI) is a common hospital-acquired infection that affects older adults, leading to increased morbidity and mortality. While there is a significant body of literature examining socio-economic and ethnic disparities in the treatment of CDI, little is known about gender-based disparities. This study aims to investigate potential gender-based disparities in CDI readmissions. Methods The present study used the Nationwide Readmissions Database (2019) to identify principal hospitalizations of adult patients with CDI. Results The study included 64,710 index admissions, with 3,436 30-day readmissions (males = 35.2%, females = 65%). Recurrent colitis due to CDI was the most common cause of readmission for males and females (32.1% and 31.8%, respectively), followed by sepsis (20.8% and 21.2%, respectively). Males had higher rates of leaving against medical advice (AMA) (1.6% vs. 1%, P < 0.001) and inpatient mortality (1.3% vs. 1.2%, P < 0.001) for CDI readmissions compared to index admissions. However, there was no significant difference in median hospital stay and charges for both genders. There was a higher frequency of leaving AMA (1.6% vs. 1%, P < 0.001) and inpatient mortality (1.3% vs. 1.2%, P < 0.001) in 30-day readmissions compared to index admissions. In comparison, females only had a higher AMA rate (1.4% vs. 0.8%, P = 0.006) for 30-day readmissions compared to index admissions. Conclusion Both genders have a higher AMA rate, but only males have a higher inpatient mortality for CDI readmissions than index admissions. There is no gender-based disparity between stay and hospital charges for CDI readmissions. Our study contributes to understanding CDI's impact on patient outcomes. Healthcare providers should remain aware of these potential disparities to ensure appropriate care for all patients with CDI, regardless of gender.
- 29 January 2024
- Published by Springer Nature in Research Square
Open AccessGender-Based Disparities in Clostridium Difficile Infections in the United States: A Population-Based Study
Introduction Clostridium difficile infection (CDI) is a common hospital-acquired infection that affects older adults, leading to increased morbidity and mortality. While there is a significant body of literature examining socio-economic and ethnic disparities in the treatment of CDI, little is known about gender-based disparities. This study aims to investigate potential gender-based disparities in CDI readmissions. Methods The present study used the Nationwide Readmissions Database (2019) to identify principal hospitalizations of adult patients with CDI. Results The study included 64,710 index admissions, with 3,436 30-day readmissions (males = 35.2%, females = 65%). Recurrent colitis due to CDI was the most common cause of readmission for males and females (32.1% and 31.8%, respectively), followed by sepsis (20.8% and 21.2%, respectively). Males had higher rates of leaving against medical advice (AMA) (1.6% vs. 1%, P < 0.001) and inpatient mortality (1.3% vs. 1.2%, P < 0.001) for CDI readmissions compared to index admissions. However, there was no significant difference in median hospital stay and charges for both genders. There was a higher frequency of leaving AMA (1.6% vs. 1%, P < 0.001) and inpatient mortality (1.3% vs. 1.2%, P < 0.001) in 30-day readmissions compared to index admissions. In comparison, females only had a higher AMA rate (1.4% vs. 0.8%, P = 0.006) for 30-day readmissions compared to index admissions. Conclusion Both genders have a higher AMA rate, but only males have a higher inpatient mortality for CDI readmissions than index admissions. There is no gender-based disparity between stay and hospital charges for CDI readmissions. Our study contributes to understanding CDI's impact on patient outcomes. Healthcare providers should remain aware of these potential disparities to ensure appropriate care for all patients with CDI, regardless of gender.